The largest database of trusted experimental protocols

Eptifibatide

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Eptifibatide is a synthetic cyclic heptapeptide that functions as a glycoprotein IIb/IIIa receptor antagonist. It inhibits the binding of fibrinogen, von Willebrand factor, and other ligands to the glycoprotein IIb/IIIa receptor, thereby preventing platelet aggregation.

Automatically generated - may contain errors

4 protocols using eptifibatide

1

Platelet Activation Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
G-Ro was obtained from Ambo Institute (Daejon, Korea). Thrombin was obtained from Chrono-Log Corporation (Havertown, PA, USA). Anti-VASP, anti-phosphor-VASP (Ser157), anti-phosphor-VASP (Ser239), anti-rabbit IgG-HRP-horseradish peroxidase conjugate (HRP), and lysis buffer were purchased from Cell Signaling (Beverly, MA, USA). The αIIb/β3 inhibitor eptifibatide, GR 144053, and anti-β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyvinylidene difluoride membrane was purchased from GE Healthcare (Piseataway, NJ, USA). Enhanced chemiluminescence solution was purchased from GE Healthcare (Chalfont St. Giles, UK). cAMP and cyclic guanosine monophosphate (cGMP) enzyme immunoassay kits were purchased from Cayman Chemical (Ann Arbor, MI, USA). An A-kinase inhibitor Rp-8-Br-cAMPS, an A-kinase activator 8-(4-chlorophenylthio)-cAMP (pCPT-cAMP), and a G-kinase activator 8-Br-cGMP were purchased from Sigma Chemical Corporation (St. Louis, MO, USA). Fibrinogen Alexa Fluor 488 conjugate was obtained from Invitrogen Molecular Probes (Eugene, OR, USA).
+ Open protocol
+ Expand
2

Investigating Integrin-Mediated Cell Adhesion

Check if the same lab product or an alternative is used in the 5 most similar protocols
G-Ro (molecular weight=957.1) was obtained from Ambo Institute (Daejon, Korea). Thrombin was obtained from Chrono-Log Corporation (Havertown, PA, USA). Anti-PI3K, anti-phosphor-PI3K p85 (Tyr458), anti-Akt, anti-phosphor-Akt (Ser473), anti-rabbit IgG-horseradish peroxidase, and lysis buffer were purchased from Cell Signaling (Beverly, MA, USA). Wortmannin (PI3K inhibitor) and miltefosine (Akt inhibitor) were purchased from Cayman Chemical (Ann Arbor, MI, USA). CytoSelect 48-well cell adhesion assay kits (fibronectin-coated, colorimetric format) were purchased from Cell Biolabs (San Diego, CA, USA). Eptifibatide (αIIb/β3 inhibitor), GR 144053 (αIIb/β3 inhibitor), and anti-β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyvinylidene difluoride (PVDF) membrane and enhanced chemiluminesence solution (ECL) were purchased from General Electric Healthcare (Amersham, Buckinghamshire, UK). Fibrinogen Alexa Fluor 488 conjugate was obtained from Invitrogen Molecular Probes (Eugene, OR, USA).
+ Open protocol
+ Expand
3

Transfection and Flow Cytometry of αIIbβ3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CHO/αIIbβ3 cells were transfected with various constructs using PolyJetTM In Vitro DNA Transfection Reagent (SignaGen Laboratories) following the manufacturer’s recommendations. When needed, eptifibatide (Santa Cruz Biotechnology) was added to a final concentration of 20 μM after transfection. One day after transfection, the cells were detached with trypsin-EDTA, spin-washed twice with DMEM, and assessed for GFP expression via flow cytometry using either FACS Calibur or FACS Symphony A1 (BD Biosciences). Alternatively, to measure PAC1 binding, washed cells were incubated with 4 μg/mL of PAC1 (BD Biosciences) for 30 min at room temperature with agitation. Following two washes, the cells were subsequently incubated with allophycocyanin-conjugated anti-mouse IgM antibody (Thermo Fisher Scientific) for 30 min at 4°C, washed again, and analyzed by flow cytometry.
+ Open protocol
+ Expand
4

Viral Pathogenesis and Platelet Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two recombinant CVB strains were used: a myocarditic CVB3 (H3) [20] and a non-myocarditic CVB1 strain [21] . Viral stocks, propagation in Vero cells and infectivity titration have been previously described [22] . The antibodies (Abs) against viral antigens and primers have been used before [23] . The blocking antiserum against CAR was generously provided by Dr J.M. Bergelson, University of Pennsylvania, USA. Eptifibatide and anti CD42b (clone HIP1) blocking antibodies were from Santa Cruz (Dallas, TX, USA) and Biolegend (San Diego, CA, USA), respectively. The antiserum against platelets have been described before [24] and was a generous gift from Dr M. Isturiz, IMEX, Argentina.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!